← Latest Filings
R
RA Capital Management, L.P.
Also a 13F filer: see its fund portfolio and quarterly moves →
Open-market buys
65
$1026.3M total
Open-market sells
97
$241.2M total
Tracking since
Oct 2025
Activity timeline
Open-market buy — $2.6M
Bambusa Therapeutics, Inc. · Nov 2, 2026
Open-market buy — $37.4M
Bambusa Therapeutics, Inc. · Nov 2, 2026
Open-market trades from the last two years.
Holdings as last reported
26,975,505 Common Stock in WVE
Held indirectly (See footnotes) · as of 2026-10-05
26,975,505 Ordinary Shares in WVE
Held indirectly (See footnotes) · as of 2026-03-30
Companies touched
Tyra Biosciences, Inc.
CIK 0001863127
Sionna Therapeutics, Inc.
CIK 0002036042
